SCHEMBL25210795

SCHEMBL25210795

c1ccc(-c2ccc3ccccc3c2-c2ccc3c(ccc4ccccc43)c2-c2cccc3ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.47
ALDH1A1 P00352 5/20 0.46
HPGD P15428 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TP53 P04637 2/20 0.46
MAPK1 P28482 2/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX12 P18054 1/20 0.46
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 1/20 0.46
SOS1 Q07889 1/20 0.43
DNMT1 P26358 1/20 0.42
MAPT P10636 3/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30021047 1.00 HPRT1 (0.47) HPRT1ALDH1A1HPGDMEN1KMT2A
Naphthalene SCHEMBL29177976 0.94 ALDH1A1 (0.42) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL30394621 0.94 DNMT1 (0.47) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL25404214 0.91 HPRT1 (0.52) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL30006027 0.91 DNMT1 (0.48) ALDH1A1HPGDMEN1KMT2ATP53
SCHEMBL18260187 0.91 DNMT1 (0.48) ALDH1A1HPGDMEN1KMT2ATP53
SCHEMBL25437991 0.90 HPRT1 (0.47) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL25403934 0.88 HPRT1 (0.48) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL30021539 0.88 HPRT1 (0.48) HPRT1ALDH1A1HPGDMEN1KMT2A
SCHEMBL30022624 0.88 DNMT1 (0.51) HPRT1ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 US disclosed
WO-2023171544-A1 MIXED POWDER, METHOD FOR MANUFACTURING MIXED POWDER, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, AND METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2023-09-14 WO disclosed
WO-2023100891-A1 SOLID MOLTEN MIXTURE, SOLID COMPOSITION, MIXED POWDER, METHOD FOR CHOOSING ORGANIC COMPOUND, METHOD FOR PRODUCING SOLID MOLTEN MIXTURE, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 HPRT1 2445/4885ALDH1A1 3661/4885HPGD 4682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.